146 related articles for article (PubMed ID: 12900476)
1. Effects of thrombolysis for acute stroke in patients with pre-existing disability.
Foell RB; Silver B; Merino JG; Wong EH; Demaerschalk BM; Poncha F; Tamayo A; Hachinski V
CMAJ; 2003 Aug; 169(3):193-7. PubMed ID: 12900476
[TBL] [Abstract][Full Text] [Related]
2. Role of preexisting disability in patients treated with intravenous thrombolysis for ischemic stroke.
Karlinski M; Kobayashi A; Czlonkowska A; Mikulik R; Vaclavik D; Brozman M; Svigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Krespi Y; Ahmed N; Wahlgren N;
Stroke; 2014 Mar; 45(3):770-5. PubMed ID: 24496395
[TBL] [Abstract][Full Text] [Related]
3. Rehabilitation outcomes of stroke patients treated with tissue plasminogen activator.
Meiner Z; Sajin A; Schwartz I; Tsenter J; Yovchev I; Eichel R; Ben-Hur T; Leker RR
PM R; 2010 Aug; 2(8):698-702; quiz 792. PubMed ID: 20709299
[TBL] [Abstract][Full Text] [Related]
4. Safety and early outcomes after intravenous thrombolysis in acute ischemic stroke patients with prestroke disability.
Cooray C; Karlinski M; Kobayashi A; Ringleb P; Kõrv J; Macleod MJ; Dixit A; Azevedo E; Bladin C; Ahmed N
Int J Stroke; 2021 Aug; 16(6):710-718. PubMed ID: 32878588
[TBL] [Abstract][Full Text] [Related]
5. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
6. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
[TBL] [Abstract][Full Text] [Related]
7. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator.
Huang YH; Zhuo ST; Chen YF; Li MM; Lin YY; Yang ML; Chen ZJ; Cai RW
Chin Med J (Engl); 2013; 126(24):4685-90. PubMed ID: 24342312
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis safety and effectiveness in acute ischemic stroke patients with pre-morbid disability.
Caruso P; Ajčević M; Furlanis G; Ridolfi M; Lugnan C; Cillotto T; Naccarato M; Manganotti P
J Clin Neurosci; 2020 Feb; 72():180-184. PubMed ID: 31875830
[TBL] [Abstract][Full Text] [Related]
10. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
11. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.
Takagi T; Kato T; Sakai H; Nishimura Y
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):69-74. PubMed ID: 23164483
[TBL] [Abstract][Full Text] [Related]
12. Predictors of long-term outcome after intravenous or intra-arterial recombinant tissue plasminogen activator treatment in the eastern Hungarian thrombolysis database.
Fekete K; Márton S; Tóth J; Csiba L; Fekete I; Bereczki D
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):117-24. PubMed ID: 25440339
[TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
[TBL] [Abstract][Full Text] [Related]
14. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
[TBL] [Abstract][Full Text] [Related]
17. Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin.
Ebinger M; Siegerink B; Kunz A; Wendt M; Weber JE; Schwabauer E; Geisler F; Freitag E; Lange J; Behrens J; Erdur H; Ganeshan R; Liman T; Scheitz JF; Schlemm L; Harmel P; Zieschang K; Lorenz-Meyer I; Napierkowski I; Waldschmidt C; Nolte CH; Grittner U; Wiener E; Bohner G; Nabavi DG; Schmehl I; Ekkernkamp A; Jungehulsing GJ; Mackert BM; Hartmann A; Rohmann JL; Endres M; Audebert HJ;
JAMA; 2021 Feb; 325(5):454-466. PubMed ID: 33528537
[TBL] [Abstract][Full Text] [Related]
18. Acute Stroke Patients With Mild-to-Moderate Pre-existing Disability Should Be Considered for Thrombolysis Treatment.
Zhang W; Coote S; Frost T; Dewey HM; Choi PMC
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2707-2711. PubMed ID: 30037650
[TBL] [Abstract][Full Text] [Related]
19. Prestroke physical activity is associated with good functional outcome and arterial recanalization after stroke due to a large vessel occlusion.
Ricciardi AC; López-Cancio E; Pérez de la Ossa N; Sobrino T; Hernández-Pérez M; Gomis M; Munuera J; Muñoz L; Dorado L; Millán M; Dávalos A; Arenillas JF
Cerebrovasc Dis; 2014; 37(4):304-11. PubMed ID: 24851928
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous thrombolysis patients with acute ischemic stroke: the analysis of the 100 cases. Part I. Characteristic of the patients and effectiveness of treatment].
Sobolewski P; Sledzińska M; Szczuchniak W; Hatalska-Zerebiec R; Grzesik M; Sobota A
Przegl Lek; 2012; 69(6):237-41. PubMed ID: 23094435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
